Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.2% |
| 2 | Healthcare | 7.6% |
| 3 | Financials | 5.15% |
| 4 | Consumer Discretionary | 5.03% |
| 5 | Industrials | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZYNE
4676
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $413K | ﹤0.01% |
325,237
+199,402
| +158% | +$174K |
|
|
CELL
4677
DELISTED
PhenomeX Inc. Common Stock
CELL
| $413K | ﹤0.01% |
413,400
-147,301
| -26% | -$113K |
|
4678
iShares Core Dividend Growth ETF
DGRO
$42.9B
| $412K | ﹤0.01% |
8,328
+2,628
| +46% | +$136K |
|
4679
Community Health Systems
CYH
$416M
| $412K | ﹤0.01% |
141,909
-1,209,029
| -89% | -$4.48M |
|
|
PAMT
4680
PAMT Corp
PAMT
$349M
| $411K | ﹤0.01% |
19,073
+4,031
| +27% | +$95.4K |
|
|
MOFG
4681
DELISTED
MidWestOne Financial Group
MOFG
| $411K | ﹤0.01% |
20,217
-20,044
| -50% | -$440K |
|
4682
GameStop
GME
$8.39B
| $410K | ﹤0.01% |
24,931
-69,138
| -73% | -$1.38M |
|
4683
The Beachbody Company
BODI
$73.4M
| $408K | ﹤0.01% |
27,689
-3,149
| -10% | -$63.2K |
|
|
PMO
4684
Franklin Municipal Opportunities Trust
PMO
$279M
| $407K | ﹤0.01% |
44,246
-16,568
| -27% | -$164K |
|
|
GHL
4685
DELISTED
Greenhill & Co., Inc.
GHL
| $406K | ﹤0.01% |
27,439
+1,337
| +5% | +$19.7K |
|
|
TPIC
4686
DELISTED
TPI Composites
TPIC
| $405K | ﹤0.01% |
152,862
-19,942
| -12% | -$122K |
|
4687
CALL
Lifezone Metals Ltd Warrants
LZM.WS
$21.4M
| $403K | ﹤0.01% |
+341,207
| New | +$296K |
|
4688
CALL
Five Below
FIVE
$11.9B
| $402K | ﹤0.01% |
2,500
-17,000
| -87% | -$3.11M |
|
|
FBMS
4689
DELISTED
The First Bancshares, Inc.
FBMS
| $402K | ﹤0.01% |
+14,898
| New | +$426K |
|
4690
Hercules Capital
HTGC
$3.15B
| $401K | ﹤0.01% |
24,420
+5,157
| +27% | +$84.4K |
|
4691
Cadre Holdings
CDRE
$1.32B
| $399K | ﹤0.01% |
14,961
-20,764
| -58% | -$507K |
|
|
IPG
4692
PUT
DELISTED
Interpublic Group of Companies
IPG
| $398K | ﹤0.01% |
13,900
-900
| -6% | -$30K |
|
|
DCH
4693
Dauch Corp
DCH
$1.38B
| $398K | ﹤0.01% |
54,842
+6,009
| +12% | +$48.3K |
|
4694
Broadwind
BWEN
$96.4M
| $397K | ﹤0.01% |
124,008
+11,668
| +10% | +$44.4K |
|
4695
WPP
WPP
$4.41B
| $396K | ﹤0.01% |
8,894
-3,482
| -28% | -$174K |
|
4696
Provident Financial
PROV
$112M
| $395K | ﹤0.01% |
30,201
-3,441
| -10% | -$46.3K |
|
4697
InflaRx
IFRX
$258M
| $395K | ﹤0.01% |
132,658
-238,453
| -64% | -$908K |
|
|
XOMA
4698
DELISTED
Xoma
XOMA
| $395K | ﹤0.01% |
28,027
-18,910
| -40% | -$297K |
|
4699
Allogene Therapeutics
ALLO
$635M
| $394K | ﹤0.01% |
124,398
-85,368
| -41% | -$374K |
|
|
MDRX
4700
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
| $394K | ﹤0.01% |
30,000
-70,000
| -70% | -$918K |
|
Similar funds
Millennium Management's Q3 2023 Portfolio in Review
As of Q3 2023, Millennium Management held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Millennium Management's Q3 2023 filing shows 836 new, 2,327 increased, 2,312 reduced and 834 closed positions. Its largest new stake was Mobileye: 2,953,164 shares worth $123M. The largest sale was iShares Core S&P 500 ETF, an estimated $689M.
By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Financials.
- Millennium Management's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Millennium Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Millennium Management fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Millennium Management's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Millennium Management opened 836 new positions and closed 834 in Q3 2023.
- Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.